Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
This certification will open new markets for the Kwality Pharma
Investment will fund expansion to meet rising demand for CRDMO services
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
New research labs and process development services to enable next generation therapeutics
he company will focus on production of any pharmaceutical and biotechnological products
Subscribe To Our Newsletter & Stay Updated
